137 related articles for article (PubMed ID: 22113009)
1. Interactions between hepatitis B virus and aflatoxin B(1): effects on p53 induction in HepaRG cells.
Lereau M; Gouas D; Villar S; Besaratinia A; Hautefeuille A; Berthillon P; Martel-Planche G; Nogueira da Costa A; Ortiz-Cuaran S; Hantz O; Pfeifer GP; Hainaut P; Chemin I
J Gen Virol; 2012 Mar; 93(Pt 3):640-650. PubMed ID: 22113009
[TBL] [Abstract][Full Text] [Related]
2. A review of molecular mechanisms in the development of hepatocellular carcinoma by aflatoxin and hepatitis B and C viruses.
Moudgil V; Redhu D; Dhanda S; Singh J
J Environ Pathol Toxicol Oncol; 2013; 32(2):165-75. PubMed ID: 24099430
[TBL] [Abstract][Full Text] [Related]
3. Interaction of aflatoxin and hepatitis B virus in the pathogenesis of hepatocellular carcinoma.
Rajagopalan MS; Busch MP; Blum HE; Vyas GN
Life Sci; 1986 Oct; 39(14):1287-90. PubMed ID: 3020328
[TBL] [Abstract][Full Text] [Related]
4. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
[TBL] [Abstract][Full Text] [Related]
6. Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection.
Villar S; Le Roux-Goglin E; Gouas DA; Plymoth A; Ferro G; Boniol M; Lereau M; Bah E; Hall AJ; Wild CP; Mendy M; Norder H; van der Sande M; Whittle H; Friesen MD; Groopman JD; Hainaut P
Environ Health Perspect; 2011 Nov; 119(11):1635-40. PubMed ID: 21768053
[TBL] [Abstract][Full Text] [Related]
7. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
[TBL] [Abstract][Full Text] [Related]
8. Human hepatitis B virus and hepatocellular carcinoma. II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1.
Yan RQ; Su JJ; Huang DR; Gan YC; Yang C; Huang GH
J Cancer Res Clin Oncol; 1996; 122(5):289-95. PubMed ID: 8609152
[TBL] [Abstract][Full Text] [Related]
9. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte polarization is essential for the productive entry of the hepatitis B virus.
Schulze A; Mills K; Weiss TS; Urban S
Hepatology; 2012 Feb; 55(2):373-83. PubMed ID: 21953491
[TBL] [Abstract][Full Text] [Related]
13. Association of aflatoxin B(1)-albumin adduct levels with hepatitis B surface antigen status among adolescents in Taiwan.
Chen SY; Chen CJ; Chou SR; Hsieh LL; Wang LY; Tsai WY; Ahsan H; Santella RM
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1223-6. PubMed ID: 11700273
[TBL] [Abstract][Full Text] [Related]
14. Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.
Xia Y; Carpentier A; Cheng X; Block PD; Zhao Y; Zhang Z; Protzer U; Liang TJ
J Hepatol; 2017 Mar; 66(3):494-503. PubMed ID: 27746336
[TBL] [Abstract][Full Text] [Related]
15. Defective DNA damage response and repair in liver cells expressing hepatitis B virus surface antigen.
Chung YL
FASEB J; 2013 Jun; 27(6):2316-27. PubMed ID: 23444429
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg).
Chittmittrapap S; Chieochansin T; Chaiteerakij R; Treeprasertsuk S; Klaikaew N; Tangkijvanich P; Komolmit P; Poovorawan Y
Asian Pac J Cancer Prev; 2013; 14(12):7675-9. PubMed ID: 24460352
[TBL] [Abstract][Full Text] [Related]
17. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.
Besaratinia A; Kim SI; Hainaut P; Pfeifer GP
Gastroenterology; 2009 Sep; 137(3):1127-37, 1137.e1-5. PubMed ID: 19524575
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B Virus Infection of HepaRG Cells, HepaRG-hNTCP Cells, and Primary Human Hepatocytes.
Ni Y; Urban S
Methods Mol Biol; 2017; 1540():15-25. PubMed ID: 27975304
[TBL] [Abstract][Full Text] [Related]
19. Control of hepatitis B virus replication by innate response of HepaRG cells.
Lucifora J; Durantel D; Testoni B; Hantz O; Levrero M; Zoulim F
Hepatology; 2010 Jan; 51(1):63-72. PubMed ID: 19877170
[TBL] [Abstract][Full Text] [Related]
20. Early inhibition of hepatocyte innate responses by hepatitis B virus.
Luangsay S; Gruffaz M; Isorce N; Testoni B; Michelet M; Faure-Dupuy S; Maadadi S; Ait-Goughoulte M; Parent R; Rivoire M; Javanbakht H; Lucifora J; Durantel D; Zoulim F
J Hepatol; 2015 Dec; 63(6):1314-22. PubMed ID: 26216533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]